Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4490-4495

  Bogazzi, Fausto ^a   Bartalena, Luigi ^b   Campomori, Alberto ^c   Brogioni, Sandra ^d   Traino, Claudio ^a   De Martino, Fabio ^b   Rossi, Giuseppe ^c   Lippi, Francesco ^d   Pinchera, Aldo ^a,b   Martino, Enio ^c,d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LITHIUM; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE; THYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; HYPERPARATHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; NAUSEA; NECK PAIN; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RELEASE; THYROTOXICOSIS; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

ANTITHYROID AGENTS; GRAVES DISEASE; IODINE RADIOISOTOPES; LITHIUM; METHIMAZOLE; PROSPECTIVE STUDIES; THYROID HORMONES; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 18644384576     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020580     Document Type: Article

References (32)

1. Bartalena L, Vitti P 2001. Hyperthyroidism and thyrotoxicosis. In: Pinchera A, ed. Endocrinology and Metabolism. London: McGraw Hill International; 161-172
2. Allahabadia A, Daykin J, Sheppard MC, Gough SCL, Franklyn JA 2001 Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 86:3611-3617
3. 131I therapy. Br Med J 1:151-154
4. Reynolds LR, Kotchen TA 1979 Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 139:651-653
5. 131I therapy for Graves' disease. N Engl J Med 311:426-432
6. Holm LE, Lundell G, Israelsson A, Dahlqvist I 1982 Incidence of hypothyroidism occurring long after iodine 131 therapy for hyperthyroidism. J Nucl Med 23:103-107
7. Tuttle RM, Patience T, Budd S 1995 Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5:343-247
8. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T 1997 The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf) 47:425-430
9. Golden AWG, Fraser TR 1969 Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioiodine. Br Med J 3:443-444
10. Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanion PW 1982 Radioiodine-induced hypothyroidism in Graves' disease: Factors associated with the increasing incidence. J Nucl Med 23:978-983
11. Marcocci C, Gianchecci D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A 1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13:513-520
12. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR 1998 Pretreatment with propylthyouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687
13. Andrade VA, Gross JL, Maia AL 2001 The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective randomized study. J Clin Endocrinol Metab 86:3488-3493
14. 131I ablation for Graves' disease. J Clin Endocrinol Metab 86:3016-3021
15. Bogazzi F, Bartalena L, Brogioni S, Scarcello G, Burelli A, Campomori A, Manetti L, Rossi G, Pinchera A, Martino E 1999 Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab 84:499-503
16. Temple R, Berman M, Robbins J, Wolff J 1972 The use of lithium in the treatment of thyrotoxicosis. J Clin Invest 51:2746-2756
17. Robbins J 1984 Perturbations of iodine metabolism by lithium. Math Biosci 72:337-347
18. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352
19. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78
20. Rago T, Chiovato L, Aghini-Lombardi F, Grasso L, Pinchera A, Vitti P 2001 Non-palpable thyroid nodules in a borderline iodine-sufficient area: Detection by ultrasonography and follow-up. J Endocrinol Invest 24:770-776
21. Traino AC, Di Martino F, Lazzeri M, Stabin MG 2000 Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 45:121-129
22. Di Martino F, Traino AC, Stabin MG, Lippi F, Bogazzi F, Campomori A, Ferdeghini M, Alberti B, Bartalena L, Vitti P, Lazzeri M, Pinchera A, Martino E 2000 A mathematical model of thyroid mass reduction after radioiodine therapy of Graves' disease. Phys Med 16:127-136
23. Glantz AS 1992 Primer of Biostatistics. New York: McGraw-Hill Inc.
24. Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA 2001 Thyroid storm in a child following radioactive iodine (RAI) therapy: A consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab 86:1865-1867
25. Hayeck A 1978 Thyroid storm following radioiodine for thyrotoxicosis. J Pediatr 93:978-980
26. Kidess AI, Caplan RH, Reynertson RH, Wickus G 1991 Recurrence of 1-131 induced thyroid storm after discontinuing glucocorticoid therapy. Wis Med J 90:463-465
27. Andrade VA, Gross JL, Maia AL 1999 Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. J Clin Endocrinol Metab 84:4012-4016
28. Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, Buell U 1999 Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication. J Clin Endocrinol Metab 84:1229-1233
29. Korber C, Schneider P, Korber-Hafner N, Hanscheid H, Reiners C 2001 Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre? Eur J Nucl Med 28:1360-1364
30. Kawamura S, Kishino B, Tajima K, Mashita K, Tarui S 1983 Serum thyroglobulin in patients with Graves' disease treated with long term antithyroid drug therapy. J Clin Endocrinol Metab 56:507-512
31. Lazarus JH 1998 Is thyroxine during lithium therapy necessary? J Endocrinol Invest 21:784-786
32. Bartalena L, Bogazzi F, Martino E 1999 Is thyroxine during lithium therapy necessary? J EndocrinoI Invest 22:220-222